user

Influence of histocompatibility genes on the clinical course of patients with relapsing-remitting multiple sclerosis treated with interferon beta-1a

被引：0
|
作者：
Fletcher, S.
Klein, T.
Pollak, L.
机构：
来源：
MULTIPLE SCLEROSIS | 2007年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S200 / S201
页数：2
相关论文
共 50 条
  • [1] Influence of histocompatibility genes on disease susceptibility and treatment response in patients with relapsing-remitting multiple sclerosis treated with interferon beta-1a
    Flechter, Shlomo
    Klein, Tirza
    Pollak, Lea
    NEUROLOGY INTERNATIONAL, 2011, 3 (01) : 17 - 21
  • [2] Interferon beta-1a in relapsing-remitting multiple sclerosis
    Blumhardt, L
    HOSPITAL MEDICINE, 1999, 60 (03): : 192 - 195
  • [3] Response to treatment with Interferon beta-1a in patients with relapsing-remitting multiple sclerosis
    Vazquez Gomez, Lazaro Aurelio
    Hidalgo Mesa, Carlos
    Broche Perez, Yunier
    Valdes Morales, Yanet
    MEDISUR-REVISTA DE CIENCIAS MEDICAS DE CIENFUEGOS, 2022, 20 (05): : 825 - 833
  • [4] Interferon beta-1a in relapsing-remitting multiple sclerosis: A meta-analysis
    Blumhardt, LD
    NEUROLOGY, 1999, 52 (06) : A498 - A498
  • [5] Rationale for early treatment with interferon beta-1a in relapsing-remitting multiple sclerosis
    Munschauer, FE
    Stuart, WH
    CLINICAL THERAPEUTICS, 1997, 19 (05) : 868 - 882
  • [6] Binding and Neutralising Antibodies in Relapsing-remitting Multiple Sclerosis Patients Treated with a Biosimilar Interferon Beta-1a (CinnoVex®)
    Sh, Nafissi
    Shahkarami, M. Amir
    Lam, R.
    Oger, J.
    MULTIPLE SCLEROSIS, 2010, 16 (02): : 273 - 273
  • [7] Effects of statins on intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis
    Rudick, R.
    Pace, A.
    Panzara, M.
    Rani, S.
    Schrock, J.
    Calabresi, F.
    Confavreux, C.
    Galetta, S.
    Lublin, F.
    Radue, E. W.
    Stuart, W.
    Weinstock-Guttman, B.
    Wynn, D.
    MULTIPLE SCLEROSIS, 2007, 13 : S57 - S57
  • [8] Gender effects on intramuscular interferon beta-1a in relapsing-remitting multiple sclerosis: analysis of 1406 patients
    Rudick, R. A.
    Kappos, L.
    Kinkel, R.
    Clanet, M.
    Phillips, J. T.
    Herndon, R. M.
    Sandrock, A. W.
    Munschauer, F. E., III
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 (03) : 353 - 360
  • [9] Relapsing-remitting Multiple Sclerosis Treated with Interferon Beta-1a 44 μg from the Onset - a Case Report
    Kurkova, B.
    Hradilek, P.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2013, 76 : 32 - 34
  • [10] PAYER AND SOCIETAL BENEFIT OF PEGINTERFERON BETA-1A VERSUS SUBCUTANEOUS INTERFERON BETA-1A IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN ITALY
    Gitlin, M.
    Snyder, S.
    Jhaveri, M.
    VALUE IN HEALTH, 2019, 22 : S746 - S746
12345